HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Antipsychotic-like profile of CIQ isomers in animal models of schizophrenia.

Abstract
Earlier, we have shown the efficacy of racemic (±) CIQ, a positive allosteric modulator of GluN2C/2D receptor against MK-801 induced impairment of prepulse inhibition as well as working memory. The present study investigated the antipsychotic-like profile of different CIQ (±, +, -) isomers against schizophrenia-like symptoms in series of behavioural animal models like apomorphine climbing, social isolation behaviour and NMDA receptor antagonist MK-801 induced cognitive deficits. Further, we also tested CIQ (±, +, -) isomers in neurodevelopmental model against MK-801induced deficits using open field test, Y-maze test and novel object recognition test. CIQ (±, +, -) isomers decreased climbing behaviour, increased social interaction and improved the MK-801 induced deficits in working memory in Y-maze. Further, CIQ (±, +) but not CIQ (-) improved the recognition memory in novel object recognition test as well as reduced hyperlocomotion and stereotyped behaviour. We conclude that CIQ (±, +) but not CIQ (-) exhibit the significant antipsychotic-like profile.
AuthorsPushparaj Gawai, Rohit Upadhyay, Sukanya G Gakare, Lopmudra Sarode, Shashank M Dravid, Rajesh R Ugale
JournalBehavioural pharmacology (Behav Pharmacol) Vol. 31 Issue 6 Pg. 524-534 (09 2020) ISSN: 1473-5849 [Electronic] England
PMID31860561 (Publication Type: Journal Article)
Chemical References
  • Antipsychotic Agents
  • NR2C NMDA receptor
  • NR2D NMDA receptor
  • Receptors, N-Methyl-D-Aspartate
  • Dizocilpine Maleate
  • Apomorphine
Topics
  • Animals
  • Antipsychotic Agents (pharmacology)
  • Apomorphine (pharmacology)
  • Disease Models, Animal
  • Dizocilpine Maleate (pharmacology)
  • Male
  • Maze Learning
  • Mice
  • Receptors, N-Methyl-D-Aspartate (drug effects)
  • Schizophrenia (drug therapy)
  • Social Interaction (drug effects)
  • Stereoisomerism
  • Stereotyped Behavior (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: